10 studies found for:    aastrom
Show Display Options
Rank Status Study
1 Completed
Has Results
Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy
Condition: Alveolar Bone Loss
Interventions: Biological: Tissue Repair Cells (TRC);   Device: Control
2 Completed Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.
Conditions: Fracture, Ununited;   Pseudarthrosis
Interventions: Procedure: Fracture surgery;   Drug: Cultured Bone Marrow Tissue
3 Completed Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation
Condition: Tooth Loss
Interventions: Procedure: Sinus lift augmentation and dental implant;   Biological: Aastrom BRCs
4 Completed Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion
Condition: Single Level Posterolateral Spinal Fusion
Interventions: Procedure: Bone Repair Cells (BRCs) with allogeneic, demineralized bone matrix;   Procedure: Spine fusion with autologous bone graft
5 Completed Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: Cardiac Repair Cells (CRCs)
6 Active, not recruiting An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)
Condition: Critical Limb Ischemia
Interventions: Biological: Ixmyelocel-T;   Other: Vehicle Control
7 Completed Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia
Condition: Peripheral Arterial Disease
Interventions: Biological: autologous bone marrow cells;   Biological: electrolyte solution (without cells)
8 Completed Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
Condition: Dilated Cardiomyopathy
Intervention: Biological: Cardiac Repair Cells (CRCs)
9 Recruiting An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)
Condition: Ischemic Dilated Cardiomyopathy (IDCM)
Interventions: Biological: ixmyelocel-T;   Other: Vehicle Control
10 Completed Bone Repair Cell (BRC) Treatment of Patients With Osteonecrosis of the Femoral Head
Condition: Osteonecrosis
Interventions: Procedure: Core decompression;   Biological: Autologous Bone Repair Plasma

Indicates status has not been verified in more than two years